Helperby Therapeutics Antimicrobial Combination Patent - Three Agents

← USPTO Patent Applications

ANTIMICROBIAL COMBINATIONS

Application US20260097045A1 Kind: A1 Apr 09, 2026

Assignee

Helperby Therapeutics Limited

Inventors

Robert J H Hammond, Anthony Coates, Yanmin Hu

Abstract

The present invention provides an antimicrobial combination comprising three different antimicrobial agents The first antimicrobial agent is selected from ceftazidime, polymyxin E, polymyxin B, and pharmaceutically acceptable derivatives thereof; the second antimicrobial agent is selected from zidovudine, doxycycline, fosfomycin and pharmaceutically acceptable derivatives thereof; and the third antimicrobial agent is selected from levofloxacin, doxycycline, fosfomycin, meropenem, rifampicin, gentamicin, polymyxin B/E, and pharmaceutically acceptable derivatives thereof; wherein the combination includes at least one of levofloxacin, doxycycline, rifampicin, fosfomycin, or a pharmaceutically acceptable derivative thereof; provided the combination is not (1) polymyxin E/B, zidovudine and rifampicin or (2) ceftazidime, zidovudine and fosfomycin. Also provided is an antimicrobial combination comprising three antimicrobial agents, wherein the first antimicrobial agent is ceftazidime or a pharmaceutically acceptable derivative thereof; the second antimicrobial agent is zidovudine or a pharmaceutically acceptable derivative thereof; and the third antimicrobial agent is polymyxin E or a pharmaceutically acceptable derivative thereof.

CPC Classifications

A61K 31/546 A61K 31/407 A61K 31/65 A61K 31/665 A61K 31/7072 A61K 38/12 A61P 31/04

Filing Date

2023-09-20

Application No.

19113206

View original document →